ArticleFrontiers in neurology2025

Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses.

Margherita Bellucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.